These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30776023)

  • 1. A promising approach to targeting type 1 IFN in systemic lupus erythematosus.
    Chaichian Y; Wallace DJ; Weisman MH
    J Clin Invest; 2019 Mar; 129(3):958-961. PubMed ID: 30776023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
    Furie R; Werth VP; Merola JF; Stevenson L; Reynolds TL; Naik H; Wang W; Christmann R; Gardet A; Pellerin A; Hamann S; Auluck P; Barbey C; Gulati P; Rabah D; Franchimont N
    J Clin Invest; 2019 Mar; 129(3):1359-1371. PubMed ID: 30645203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood dendritic cells and DC-poietins in systemic lupus erythematosus.
    Gill MA; Blanco P; Arce E; Pascual V; Banchereau J; Palucka AK
    Hum Immunol; 2002 Dec; 63(12):1172-80. PubMed ID: 12480261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting interferons in systemic lupus erythematosus: current and future prospects.
    Mathian A; Hie M; Cohen-Aubart F; Amoura Z
    Drugs; 2015 May; 75(8):835-46. PubMed ID: 25940912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus.
    Hartmann S; Biliouris K; Naik H; Rabah D; Stevenson L; Shen C; Nestorov IA; Lesko LJ; Trame MN
    J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):255-266. PubMed ID: 32335844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.
    Felten R; Scher F; Sagez F; Chasset F; Arnaud L
    Drug Des Devel Ther; 2019; 13():1535-1543. PubMed ID: 31190735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.